Literature DB >> 29353347

Serum pepsinogen levels indicate the requirement of upper gastrointestinal endoscopy among Group A subjects of ABC classification: a multicenter study.

Daisuke Chinda1, Tadashi Shimoyama2, Tatsuya Mikami3, Tetsu Arai1, Daisuke Chiba1, Yoshio Sasaki4, Kazuo Komai5, Yoshihiko Sawada6, Yoshiharu Saito7, Hironobu Chiba8, Shinsaku Fukuda1.   

Abstract

BACKGROUND: ABC classification has been used to assess the risk for gastric cancer. The current problem of ABC classification is that Group A contains individuals with current and past H. pylori infection. The aims of this study were to assesse the proportion of current and past infection in Group A and to establish a criteria for the identification of subjects with past infection from Group A subjects with negative results of urea breath test (UBT) and/or stool antigen test.
METHODS: 201 subjects classified into Group A received UBT and/or stool antigen test, and also subsequent upper gastrointestinal endoscopy. The subjects were classified by the status of H. pylori infection defined by endoscopic findings. Levels of pepsinogen (PG) I, PG II and PG I/II ratio were compared between the groups, and receiver operating characteristic curves were constructed to extract the corresponding cutoff values.
RESULTS: 22 subjects were tested positive by UBT and/or stool antigen test. Endoscopic images of 157 out of 179 subjects were studied. 15 of the subjects were regarded to have past H. pylori infection. The optimal cut-off value of PG I and PG I/II ratio for the determination of past H. pylori infection were ≤ 31.2 ng/mL and ≤ 4.6, respectively.
CONCLUSIONS: Approximately 20% of Group A subjects have current or past H. pylori infection. Addition of UBT and/or stool antigen test can identify current but not past infection. Serum PG levels would be useful to identify subjects with past H. pylori infection.

Entities:  

Keywords:  Group A of ABC classification; Helicobacter pylori infection; Pepsinogen levels; Upper gastrointestinal endoscopy

Mesh:

Substances:

Year:  2018        PMID: 29353347     DOI: 10.1007/s00535-018-1431-9

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  32 in total

1.  Frequency of Helicobacter pylori -negative gastric cancer and gastric mucosal atrophy in a Japanese endoscopic submucosal dissection series including histological, endoscopic and serological atrophy.

Authors:  Shouko Ono; Mototsugu Kato; Mio Suzuki; Saori Ishigaki; Masakazu Takahashi; Masahira Haneda; Katsuhiro Mabe; Yuichi Shimizu
Journal:  Digestion       Date:  2012-06-20       Impact factor: 3.216

2.  Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese.

Authors:  Taiji Matsuo; Masanori Ito; Shunsuke Takata; Shinji Tanaka; Masaharu Yoshihara; Kazuaki Chayama
Journal:  Helicobacter       Date:  2011-12       Impact factor: 5.753

3.  Fasting gastric pH of Japanese subjects stratified by IgG concentration against Helicobacter pylori and pepsinogen status.

Authors:  Hiroshi Kishikawa; Jiro Nishida; Hitoshi Ichikawa; Shogo Kaida; Sakiko Takarabe; Takashi Matsukubo; Soichiro Miura; Tetsuo Morishita; Toshifumi Hibi
Journal:  Helicobacter       Date:  2011-12       Impact factor: 5.753

4.  Predicting the development of gastric cancer from combining Helicobacter pylori antibodies and serum pepsinogen status: a prospective endoscopic cohort study.

Authors:  H Watabe; T Mitsushima; Y Yamaji; M Okamoto; R Wada; T Kokubo; H Doi; H Yoshida; T Kawabe; M Omata
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

5.  Studies of 13C-urea breath test for diagnosis of Helicobacter pylori infection in Japan.

Authors:  S Ohara; M Kato; M Asaka; T Toyota
Journal:  J Gastroenterol       Date:  1998-02       Impact factor: 7.527

6.  The serum pepsinogen test as a predictor of gastric cancer: the Hisayama study.

Authors:  Yoshinori Oishi; Yutaka Kiyohara; Michiaki Kubo; Keiichi Tanaka; Yumihiro Tanizaki; Toshiharu Ninomiya; Yasufumi Doi; Kentaro Shikata; Koji Yonemoto; Tomoko Shirota; Takayuki Matsumoto; Mitsuo Iida
Journal:  Am J Epidemiol       Date:  2006-01-27       Impact factor: 4.897

7.  Serum pepsinogens as a predicator of the topography of intestinal metaplasia in patients with atrophic gastritis.

Authors:  Yoshihisa Urita; Kazuo Hike; Naotaka Torii; Yoshinori Kikuchi; Eiko Kanda; Masahiko Sasajima; Kazumasa Miki
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

8.  Long-term results of gastric cancer screening using the serum pepsinogen test method among an asymptomatic middle-aged Japanese population.

Authors:  Kazumasa Miki; Mitsuhiro Fujishiro; Shinya Kodashima; Naohisa Yahagi
Journal:  Dig Endosc       Date:  2009-04       Impact factor: 7.559

9.  Risk of gastric cancer in asymptomatic, middle-aged Japanese subjects based on serum pepsinogen and Helicobacter pylori antibody levels.

Authors:  Kimihiko Yanaoka; Masashi Oka; Noriko Yoshimura; Chizu Mukoubayashi; Shotaro Enomoto; Mikitaka Iguchi; Hirohito Magari; Hirotoshi Utsunomiya; Hideyuki Tamai; Kenji Arii; Nobutake Yamamichi; Mitsuhiro Fujishiro; Tatsuya Takeshita; Osamu Mohara; Masao Ichinose
Journal:  Int J Cancer       Date:  2008-08-15       Impact factor: 7.396

10.  Effect of anti-Helicobacter pylori IgG antibody titer following eradication of Helicobacter pylori infection.

Authors:  Wasaburo Koizumi; Satoshi Tanabe; Hiroshi Imaizumi; Ken-ichi Hibi; Mitsuhiro Kida; Masahito Ohida; Isao Okayasu; Katsunori Saigenji
Journal:  Hepatogastroenterology       Date:  2003 Jan-Feb
View more
  4 in total

1.  Lifestyle Factors Rather Than Helicobacter pylori Infection or Estradiol Level are Associated With Osteopenia in Japanese Men.

Authors:  Daisuke Chinda; Tadashi Shimoyama; Kaori Sawada; Chikara Iino; Hirotake Sakuraba; Shigeyuki Nakaji; Shinsaku Fukuda
Journal:  Am J Mens Health       Date:  2019 Mar-Apr

Review 2.  Previous Helicobacter pylori infection-induced atrophic gastritis: A distinct disease entity in an understudied population without a history of eradication.

Authors:  Hiroshi Kishikawa; Keisuke Ojiro; Kenji Nakamura; Tadashi Katayama; Kyoko Arahata; Sakiko Takarabe; Soichiro Miura; Takanori Kanai; Jiro Nishida
Journal:  Helicobacter       Date:  2019-11-03       Impact factor: 5.753

3.  The Optimal Cut-off of the Latex Immunoassay (LZ Test) for Helicobacter pylori Infection Based on the Stool Antigen Test and Helicobacter pylori-associated Gastritis.

Authors:  Takako Takayama; Hideo Suzuki; Kosuke Okada; Shintaro Akiyama; Toshiaki Narasaka; Kazushi Maruo; Taku Sakamoto; Emiko Seo; Kiichiro Tsuchiya
Journal:  Intern Med       Date:  2022-07-15       Impact factor: 1.282

Review 4.  What Is New in Helicobacter pylori Diagnosis. An Overview.

Authors:  Maria Pina Dore; Giovanni Mario Pes
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.